10X Genomics Inc Class A (TXG) returns
10X Genomics returns over 5 years
$1,000 invested in 10X Genomics five years ago was worth $434.74 at the close on October 30, 2026, with dividends reinvested: an average return of -15.3% a year. The same $1,000 in the S&P 500 (SPY) became $1,760.
Total return by period
| Period | Total return | A year, on average | $1,000 became | S&P 500 (SPY) |
|---|---|---|---|---|
| 1 month | -22.4% | — | $775.90 | -0.9% |
| 3 months | +41.8% | — | $1,418 | +2.1% |
| Year to date | +329.9% | — | $4,299 | +11.7% |
| 1 year | +463.6% | — | $5,636 | +12.4% |
| 3 years | +96.1% | +25.2% | $1,961 | +88.5% |
| 5 years | -56.5% | -15.3% | $434.74 | +76.0% |
10X Genomics return by calendar year
| Year | TXG | S&P 500 (SPY) | Difference |
|---|---|---|---|
| 2026 to date | +329.9% | +11.7% | +318.2% |
| 2025 | +13.6% | +17.7% | -4.1% |
| 2024 | -74.3% | +24.9% | -99.2% |
| 2023 | +53.6% | +26.2% | +27.4% |
| 2022 | -75.5% | -18.2% | -57.4% |
| 2021 | +5.2% | +28.7% | -23.5% |
| 2020 | +85.7% | +18.4% | +67.3% |
Past returns do not predict future returns. Returns are computed from our daily closes, adjusted for splits and with dividends reinvested on their ex-dates; taxes and trading costs are left out.
See also: TXG financials
No forecast, no recommendation. This page describes 10X Genomics Inc Class A from published data; it is not advice to buy, sell or hold any security.
Figures as of the close on Oct 30, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.